Premium
TREATMENT BENEFIT ASSOCIATING WITH NON‐ANTHRACYCLINE CHEMOTHERAPY IN EXTRANODAL NK/T‐CELL LYMPHOMA, NASAL TYPE
Author(s) -
Qi S.,
Yang Y.,
Liu W.,
Zhang L.,
Su H.,
Yang Y.,
He X.,
Qu B.,
Qian L.,
Hou X.,
Wang H.,
Li G.,
Zhang Y.,
Qiao X.,
Zhu Y.,
Cao J.,
Wu J.,
Wu T.,
Zhu S.,
Shi M.,
Xu L.,
Li Y.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.65_2629
Subject(s) - medicine , chemotherapy , anthracycline , regimen , gastroenterology , cohort , lymphoma , retrospective cohort study , oncology , t cell lymphoma , surgery , cancer , breast cancer